User profiles for Roberto Lorenzetti

ROBERTO LORENZETTI

dirigente medico gastroenterologia asl roma1
Verified email at aslroma1.it
Cited by 3062

Efficacy of real-time computer-aided detection of colorectal neoplasia in a randomized trial

…, M Di Leo, V Craviotto, L Lamonaca, R Lorenzetti… - Gastroenterology, 2020 - Elsevier
Background & Aims One-fourth of colorectal neoplasias are missed during screening
colonoscopies; these can develop into colorectal cancer (CRC). Deep learning systems allow for …

[HTML][HTML] Impact of artificial intelligence on miss rate of colorectal neoplasia

…, P Bhandari, J East, G Antonelli, R Lorenzetti… - Gastroenterology, 2022 - Elsevier
Background & Aims Artificial intelligence (AI) may detect colorectal polyps that have been
missed due to perceptual pitfalls. By reducing such miss rate, AI may increase the detection of …

[HTML][HTML] Follow-up of intestinal metaplasia in the stomach: When, how and why

…, M Giusto, C Guerriero, R Lorenzetti… - World journal of …, 2012 - ncbi.nlm.nih.gov
Gastric cancer remains the second most frequent cause of cancer-related mortality in the
world. Screening programs in some Asian countries are impractical in the majority of other …

[HTML][HTML] Artificial intelligence allows leaving-in-situ colorectal polyps

C Hassan, G Balsamo, R Lorenzetti, A Zullo… - Clinical …, 2022 - Elsevier
Background & Aims Artificial Intelligence (AI) could support cost-saving strategies for colonoscopy
because of its accuracy in the optical diagnosis of colorectal polyps. However, AI must …

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

R Lorenzetti, A Zullo, L Ridola, AP Diamanti… - Annals of …, 2014 - Taylor & Francis
Objective. Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized
as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB …

Computer-aided detection-assisted colonoscopy: classification and relevance of false positives

…, V Craviotto, L Lamonaca, R Lorenzetti… - Gastrointestinal …, 2020 - Elsevier
Background and Aims False positive (FP) results by computer-aided detection (CADe) hamper
the efficiency of colonoscopy by extending examination time. Our aim was to develop a …

[HTML][HTML] Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with …

…, A Beccacece, S Vita, V Bruzzese, R Lorenzetti… - International Journal of …, 2022 - Elsevier
Objectives: In this study, we aimed to characterize the SARS-CoV-2-specific T cell response
detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy …

[HTML][HTML] Linking estrogen receptor β expression with inflammatory bowel disease activity

…, C Barbati, P Cesaro, C Spada, A Zullo, R Lorenzetti… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Crohn disease (CD) and ulcerative colitis (UC) are chronic forms of inflammatory bowel disease
(IBD) whose pathogenesis is only poorly understood. Estrogens have a complex role in …

Adalimumab in active ulcerative colitis: a “real-life” observational study

…, P Gionchetti, S Gozzi, A Kohn, R Lorenzetti… - Digestive and Liver …, 2013 - Elsevier
Background and aims The effectiveness of adalimumab in the treatment of ulcerative colitis
is under debate. Although controlled trials have shown that adalimumab is significantly better …

Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients

A Tursi, G Mocci, R Lorenzetti, L Allegretta… - European Journal of …, 2021 - journals.lww.com
Background Infliximab and adalimumab are widely used for the treatment of Crohn’s disease
and ulcerative colitis. Aim To compare the long-term efficacy and safety of infliximab and …